InvestorsHub Logo
Followers 48
Posts 2221
Boards Moderated 1
Alias Born 01/28/2013

Re: Alleyba1 post# 15890

Monday, 02/24/2014 2:37:26 AM

Monday, February 24, 2014 2:37:26 AM

Post# of 24848

Alleyba says................

........The acquisition of the compound pharmacy illustrates the innovative plan and strategy the CEO has for this company.


This is yet another factually incorrect statement about SCRC. Not only does the PR clearly state that SCRC only entered into a mgmt agreement to run the day-to-day operations of the compounding pharmacy (as opposed to ACQUIRING it), but you have been specifically reminded of this fact just a few days ago as well.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=97614763

So that everyone is clear as to what SCRC's relationship w/this compounding pharmacy is, here it is straight from the SCRC horse's mouth:

TYSONS CORNER, Va., Feb 20, 2014 (GLOBE NEWSWIRE via COMTEX) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a business management agreement with a New Jersey compounding pharmacy.
The agreement states that ScripsAmerica will manage all business operations of the pharmacy which specializes in compounding topical pain creams, in exchange for a percentage of its total revenue.



Repeatedly posting statements that SCRC has "acquired" this compounding pharmacy is yet another example of the touting of mis-information that is misleading to both current and prospective shareholders.

It is a BIG difference to say that SCRC "acquired" another business because "acquired" implies "ownership" and ownership is understood to mean that the acquired business' revenues all flow up to SCRC. This is NOT the case by any stretch of the imagination. SCRC, under what has been disclosed in the PR, will receive a mgmt fee for its services that is determined by an undisclosed amount of basis points applied against this business' revenues -- in essence, simply an unknown percentage, but which can be safely concluded to be significanty less than 100% of revenues.